. Nucleotide Sequence of the Aplysia CREB1 Gene and Amino Acid Sequences of the Aplysia CREB1 Protein Isoforms (A) CREB1 protein sequences were deduced from DNA sequences of Aplysia genomic clones and CREB1␣ and CREB1␤ cDNAs from a sensory neuron cDNA library. Exons are indicated by the roman numerals on the left side. The partial nucleotide sequence annotated as exon I was derived from the longest 5Ј end of CREB1␣ cDNA. The intron boundaries (GT and AG) are bold. Only partial intron sequences and partial untranslated 3Ј end of cDNAs are shown. In both CREB1␣ and CREB1␤ cDNAs, the first ATG is surrounded by Kozak sequence (Kozak, 1986b) and was assigned as the translation start. The numbering of the protein sequence on the right side starts with this first methionine as #1 and refers to the CREB1a protein isoform. CREB1␤ mRNA is generated by splicing-out of exon IV (shaded) and encodes the CREB1c and CREB1b protein isoforms. The C-terminal end of CREB1c is indicated by the arrowhead. The ATG for methionine 196 (referring to the CREB1␣ protein, bold) is also surrounded by the Kozak sequence and is the putative initiation codon for the CREB1b protein isoform translated from the CREB1␤ mRNA. The leucine residues forming the leucine zipper are circled. (B) Schematic organization of the Aplysia CREB1␣ and CREB1␤ mRNAs. Exons, numbered I-VII, are shown as boxes, introns as connecting lines. The coding regions are shaded; noncoding regions are white. The new coding sequence in CREB1c generated by alternative splicing of CREB1␤ is striped. The open reading frame for individual CREB1c protein isoforms are underlined.
isoforms of CREB1 play a distinct role in synaptic plasdimerization domain (bZIP) and its phosphorylation domain (P box). The key regulatory phosphorylation conticity in the sensory neurons. CREB1a protein is an activator that is both necessary and sufficient for long-term sensus sites in the P box (Gonzalez et al., 1989) are conserved between Aplysia CREB1a and mammalian facilitation. CREB1b is a repressor of CREB1a and longterm facilitation. CREB1c is a cytoplasmic polypeptide CREBs. The S85 (corresponding to S133 in mammalian CREB) and the surrounding recognition sequences for that modulates both short-term and CREB1a-mediated long-term facilitation.
PKA, CaMK, and RSK2 are also conserved. Interestingly, similar to Drosophila dCREB2a (Yin et al., 1995a) , the T81 preserves the GSK3 phosphorylation site, homoloResults gous to S129 in mammalian CREBs (Fiol et al., 1994) . In contrast to Drosophila dCREB2a and Hydra CREB CREB1 Gene Encodes Three Proteins Homologous to Mammalian CREB and CREM (Galliot et al., 1995) , the P box in Aplysia CREB1a contains the CAMKII phosphorylation site S94, homoloWe cloned two mRNAs expressed in Aplysia sensory neurons: CREB1␣ and CREB1␤. The genomic sequence gous to S142 in mammalian CREB (Sun et al., 1994 ; Figure 1A ). of Aplysia CREB1 indicates that these two transcripts are generated by alternative splicing and that the 86
In addition to being homologous to mammalian CREB proteins, Aplysia CREB1a is also homologous to mamnucleotide insertion in CREB1␣ corresponds to the spliced-in exon IV (Figure 1) . The longest open reading malian CREM proteins in its P box (E92), bZIP domain (L218), and other motifs (for example, amino acids 56-68 frame (ORF) in the CREB1␣ cDNA encodes a CREB1a polypeptide of 271 amino acids, which has sequence and 204-206, Figure 1 ). However, Aplysia CREB1 gene does not have a second bZIP domain, a feature typical homology to both mammalian CREB and CREM proteins (Foulkes et al., 1991; Ruppert et al., 1992) . The first for CREM genes. The Aplysia CREB1 gene most likely resembles an evolutionarily early form of the gene that ORF in the CREB1␤ mRNA encodes the 99-amino acid CREB1c polypeptide in which the C-terminal 12 amino duplicated in higher eukaryotes to form the CREB and CREM genes. Consistent with this idea, CREB1 appears acids are different from CREB1a (Figure 1 ).
CREB1a is 95% homologous to mammalian CREB to be the only CREB/CREM/ATF-1-like gene in the Aplysia genome. We failed to identify any additional and CREM proteins in its C-terminal DNA binding and genomic sequences with significant homology to CREB1, CREM, or ATF1 using PCR analysis, screening of genomic library, and Southern blot hybridization with the CREB1a cDNA probe at low stringency.
The CREB1␣ mRNA Encodes the CREB1a Activator The CREB1␣ mRNA encodes a CREB1a protein with a predicted molecular weight of 29 kDa, which migrates at 40 kDa in SDS gels ( Figures 3B and 3C) . Aplysia CREB1a forms homodimers in the yeast two-hybrid system, and Gal4-CREB1a fusion protein activates transcription in yeast (data not shown). In addition, bacterially expressed recombinant CREB1a protein forms homodimers and binds to CRE in vitro ( Figure 2B ).
Transient transfection assays in F9 cells show that CREB1␣ mRNA encodes a PKA-dependent transcriptional activator (Figure 2A ). Similar to mammalian CREB proteins, the mutation of S85 to A85 (S85A mutant, homologous to S133A in mammalian CREBs) generates a dominant-negative CREB1a mutant that inhibits CREB1a-mediated transactivation in transfection assays. Consistent with the conservation of the P box in CREB1a, recombinant CREB1a protein is a substrate for in vitro phosphorylation on S85 by PKA, CaMKII, and PKC (data not shown). Thus, the Aplysia CREB1 gene encodes a protein, CREB1a, that is structurally and functionally removes the S94 and S95 of CREB1a P box. Interestingly, in mammalian CREBs, the S94 homolog S142 is a substrate for CaMKII phosphorylation, which inhibits domains and is not phosphorylated by PKA, CaMKII, or PKC in vitro (data not shown). CREB activity (Sun et al., 1994) .
CREB1b is translated from the second ORF in CREB1␤ In contrast to CREB1c, CREB1b forms homodimers as well as heterodimers with CREB1a, both of which mRNA ( Figure 1B ) and is most likely generated by internal initiation of translation, putatively at M196 (referring bind to CRE in vitro ( Figure 2B ). Transient transfections in F9 cells indicate that CREB1␤ mRNA encodes to CREB1a protein sequence, Figure 1A ). The CREB1b product of in vitro translation of full-length CREB1␤ a repressor of CREB1a-mediated transactivation. Cotransfection of CREB1b ORF (nucleotides 502-733) mRNA comigrates in gel with the product of truncated CREB1␤ (502-733) mRNA. CREB1b contains the C-terand CREB1␣ cDNA indicates that CREB1b represses CREB1a-mediated transactivation of the CRE reporter minal bZIP DNA binding and dimerization domain of CREB1a but does not contain its P box or activation ( Figure 2A ).
These results indicate that two mRNAs transcribed from the CREB1 gene encode three proteins. The CREB1␣ mRNA encodes the CREB1a transcriptional activator, and the bicistronic CREB1␤ mRNA encodes two additional CREB1 isoforms: the first ORF encodes CREB1c that lacks the bZIP domain and has a P box with modified kinase affinity; the second ORF encodes CREB1b, a transcriptional repressor.
In Aplysia Neurons, CREB1a and CREB1b Are Nuclear Proteins and CREB1c Is Cytoplasmic We next analyzed whether both CREB1␣ and CREB1␤ mRNAs are expressed in sensory neurons. Using RT-PCR with primers derived from Aplysia CREB1 exon III and exon VI sequences, we found that sensory neurons express both mRNAs. In sensory neurons, the CREB1␤ mRNA is approximately ten times more abundant than CREB1␣, and the CREB1␣/CREB1␤ mRNA ratio does not change with one or five pulses of 5-HT ( Figure 3A ).
Western blotting of extracts from Aplysia sensory neurons with affinity-purified anti-CREB1 antibodies (R1) revealed three polypeptides with apparent molecular weights corresponding to CREB1a, CREB1b, and CREB1c ( Figure 3C ). Affinity-purified antibodies against the P box peptide of CREB1a (153) as well as anti-phospho-P box peptide antibodies (395) recognize CREB1a and CREB1c proteins ( Figure 3B ). In nuclear extracts from Aplysia sensory neurons, the gel-shift assay detects three complexes binding to the CRE oligonucleotide that are supershifted by the anti-CREB1a (R1) antibody ( Figure 3D ). These data indicate that the Aplysia sensory neurons express all three CREB1 isoforms: CREB1a, CREB1b, and CREB1c.
We next analyzed the subcellular localization of CREB1 were interested in the localization of CREB1c, which CREB1a, CREB1b, and CREB1c lacks a nuclear localization signal and is found predomi- body had no effect on short-term facilitation or basal (C) CREB1a, CREB1b, and CREB1c proteins are expressed in synaptic transmission ( Figure 4A ).
Aplysia sensory neurons. Proteins isolated from six pleural sensory neuron clusters separated by SDS-PAGE were electroblotted and probed with the affinity-purified CREB1 (R1) antibodies. The positions of CREB1 isoforms are indicated. detected by EMSA. The arrows indicate the positions of three CRE (D) Three CRE binding complexes containing CREB1 proteins can binding complexes specifically supershifted by anti-CREB1 antibe detected in Aplysia sensory neurons. Nuclear extract from Aplysia body (*) in lane 2. sensory neurons were incubated with 32 P-labeled (1) CRE, (2) CRE ϩ (E) In Aplysia neurons, CREB1a and CREB1b proteins are nuclear anti-CREB1 antibody R1, (3) CRE ϩ anti-ApC/EBP antibody, (4) and the CREB1c protein is cytoplasmic. Cytoplasmic (S) and nuclear CRE ϩ 50ϫ molar excess of mutated CRE competitor, (5) CRE ϩ (Nu) fractions from Aplysia neurons were separated by SDS-PAGE, 5ϫ molar excess of specific CRE competitor, (6) CRE ϩ 50ϫ molar electroblotted, and probed with the affinity-purified CREB1 (R1) antiexcess of specific CRE competitor, and the DNA/protein complexes bodies. The positions of CREB1 isoforms are indicated. We next injected, into the sensory neurons, an antiboundary between exons IV and V. Injection of As IV/V again selectively blocked long-term facilitation (Figure sense oligonucleotide (As I/II) complementary to the sequence surrounding the first putative initiation codon. 4D). In contrast, injection of neither As IV/V nor the scrambled As SCIV/V oligonucleotide affected shortThe As I/II inhibited long-term facilitation when injected 4 hr prior to five pulses of 5-HT (21.99% Ϯ 13.42%, term facilitation ( Figure 4C ). These experiments indicate that CREB1 proteins, and n ϭ 11). By contrast, cells injected with a scrambled oligonucleotide (As SCI/II) paired with five pulses of 5-HT specifically CREB1a, are necessary for the induction of long-term facilitation. underwent the same increase in synaptic strength (99.64% Ϯ 14.53%, n ϭ 6) evident in noninjected cells (103.84% Ϯ 19.19%, n ϭ 10). Short-term facilitation,
CREB1a Is Limiting for Long-Term Facilitation
To investigate further the role of CREB1a in the induction induced by a single pulse of 5-HT, was not affected by injection of As I/II or As SCI/II and was comparable of long-term facilitation, we purified recombinant wildtype CREB1a and mutant S85A CREB1a proteins from to short-term facilitation in uninjected control neurons. Oligonucleotide injection did not affect basal synaptic E. coli and exposed them to PKA in vitro prior to injecting them into sensory neurons. We then examined the effect transmission (data not shown).
To investigate further the specific role of CREB1a in of injecting phosphorylated or unphosphorylated CREB1a on basal synaptic transmission, short-term, and longlong-term facilitation, we injected an antisense oligonucleotide (As IV) that specifically targets sequences corterm facilitation ( Figure 5 ). Injection of recombinant CREB1a, either phosphoryresponding to exon IV in CREB1␣ mRNA and therefore interferes selectively with CREB1a expression. Injection lated or unphosphorylated, had no effect on basal synaptic transmission, short-term facilitation, or long-term of As IV inhibited long-term facilitation when injected 2, 4, or 6 hr before five pulses of 5-HT (35.51% Ϯ 17.72%, facilitation. These results indicate that long-term facilitation produced by five pulses of 5-HT is saturated at n ϭ 12; 13.45% Ϯ 11.88%, n ϭ 8; 17.70% Ϯ 8.53%, n ϭ 12). In contrast, cells injected with scrambled oligonu-24 hr. To determine whether CREB1a could rescue the inhibition of long-term facilitation caused by injection of cleotide (As SCIV) 4 hr before five pulses of 5-HT showed an increase in synaptic strength comparable to that of antisense oligonucleotide targeting the CREB1␣ mRNA, we coinjected the As IV/V oligonucleotide together with noninjected cells ( Figure 4D ). Short-term facilitation was comparable in As IV-injected, As SCIV-injected, and
CREB1a protein and applied five pulses of 5-HT. CREB1a injection rescues the long-term facilitation inhibited by uninjected neurons ( Figure 4C ).
Finally, we injected an antisense oligonucleotide (As antisense targeting of CREB1a and indicates that this block was caused by depletion of CREB1a in Aplysia IV/V) that specifically targets CREB1␣ mRNA and interferes with the expression of CREB1a by binding to the neurons. In contrast, long-term facilitation induced by five pulses of 5-HT was selectively blocked by injection of a dominant-negative mutant S85A CREB1a.
To determine whether CREB1a is limiting for the conversion of short-to long-term facilitation, we next examined the effect of injecting CREB1a paired with only a single pulse of 5-HT, which normally produces shortterm facilitation only lasting minutes. When injected 1 hr before one pulse of 5-HT, both the unphosphorylated and phosphorylated CREB1a induced long-term facilitation that was at least 50% of that normally expressed after five pulses of 5-HT, thus indicating that the CREB1a is limiting in the initiation of the long-term process (Figure 5A ).
Phosphorylated CREB1a Is Sufficient for Long-Term Facilitation
To ask whether CREB1a is sufficient to induce longterm facilitation by itself, without exposing the neurons to 5-HT, we injected PKA-phosphorylated CREB1a and found that it induced significant long-term facilitation even without 5-HT exposure ( Figure 5A ). This induction of long-term facilitation by phosphorylated CREB1a was abolished by application of either the RNA synthesis inhibitor actinomycin D or the protein synthesis inhibitor anisomycin ( Figure 5C ). To determine whether phosphorylation of S85 was required for the induction of longterm facilitation, we injected unphosphorylated CREB1a and found that it induced about 30% of long-term facilitation induced by phosphorylated CREB1a. Since the injection of the dominant-negative mutant S85A CREB1a produced a depression at 24 hr, similar to that seen in uninjected cells, we think that the facilitation produced by the injection of unphosphorylated CREB1a is likely the result of subsequent intracellular phosphorylation of CREB1a by second messenger pathways induced by the microelectrode penetration and Ca 2ϩ influx. Figure 5C shows the time course of the synaptic changes following CREB1a injection. Long-term facilitation induced by phosphorylated CREB1a occurred in In Aplysia neurons in vivo, both CREB1a and CREB1c
This long-term facilitation was abolished by inhibitors of both mRNA (actinomycin D) and protein (anisomycin) synthesis.
are phosphorylated in the basal state, and exposure of intact Aplysia to 5-HT induces further phosphorylation ( Figure 6 ). CREB1a phosphorylation in response to 5-HT exposure has two phases. First there is a transient phosphorylation that begins 10 min after exposure to 5-HT, peaks at 20 min, and returns to baseline by 40 min. This transient phosphorylation is not accompanied by an increase in the concentration of the CREB1a protein ( Figure 6A) . A second phase of phosphorylation emerges after 1 hr and increases for the next 12 hr, even after the 5-HT exposure was terminated. During this second phase, the increase in CREB1a phosphorylation is accompanied by an increase in the concentration of CREB1a protein. This increase in CREB1a concentration persists for at least 12 hr after terminating the exposure to 5-HT ( Figure 6B ) and is associated with an increase in the steady-state level of CREB1 mRNA ( Figure 6E ), indicating that the second phase of CREB1a phosphorylation is likely to involve transcriptional and posttranscriptional modifications of the expression of CREB1a. In contrast, the concentration of CREB1a in neurons did not significantly change during a 12 hr incubation in the presence of either the RNA synthesis inhibitor actinomycin D or the protein synthesis inhibitor anisomycin (Figure 6F) .
CREB1c protein is phosphorylated 40 min after 5-HT exposure in vivo, and this phosphorylation persists 8 hr after 5-HT withdrawal ( Figures 6C and 6D) . The persistent increase in CREB1c phosphorylation is not accompanied by the increase in CREB1c protein concentration. Thus, CREB1a and CREB1c protein expression and phosphorylation are differentially regulated in Aplysia neurons by transcriptional and posttranscriptional mechanisms. phosphorylated recombinant CREB1a was significant, Proteins isolated from Aplysia CNS (20 g) were separated by SDSits amplitude was 50% of that produced by five pulses PAGE, electroblotted, and probed with affinity-purified phospho-P-box CREB1 (395) antibodies and anti-P box CREB1 (153) in Aplysia neurons without changing CREB1c protein concentration.
As indicated above, CREB1b is a nuclear protein that We next injected an antisense oligonucleotide (As III/ seawater were incubated with 50 g/ml of actinomycin D (Actino) V) that specifically targets the boundaries between exor 10 M anisomycin (Aniso) for the time indicated. Protein extracts ons III and V in CREB1␤ mRNA and therefore interferes were isolated as in (A) and probed with anti-P box CREB1 (153) only with the expression of CREB1␤ mRNA. In contrast antibodies.
to the injection of As IV/V, which specifically targets the CREB1␣ mRNA, the injection of As III/V did not inhibit from the bicistronic CREB1␤ mRNA. Since our antibodlong-term facilitation when paired with five pulses of ies do not allow us to measure the effects on CREB1c 5-HT. In fact, the injection of As III/V lowered the threshexpression of antisense injections by immunochemistry, old for long-term facilitation ( Figure 7E ). Thus, whereas we attempted to address this issue by injecting the puria single pulse of 5-HT produced only a transient shortfied recombinant CREB1c protein into the sensory neuterm facilitation in uninjected cells or in cells injected rons and monitoring both short-and long-term faciliwith scrambled oligonucleotide (As SCIII/V), a single tation. pulse of 5-HT produced full long-term facilitation in cells To determine whether CREB1c enhances short-term injected with As III/V ( Figure 7E ). These data indicate facilitation, we injected recombinant CREB1c peptide, that bicistronic CREB1␤ mRNA encodes a CREB1b proeither phosphorylated by PKA on S85 or unphosphorytein that is a repressor of CREB1a-mediated transcriplated, into sensory neurons. The injection of phosphorytion and of long-term facilitation. lated or unphosphorylated CREB1c had no effect on basal synaptic transmission or on short-or long-term facilitation (data not shown). By contrast, injection of CREB1c Is a Cytoplasmic Modulator for Both unphosphorylated CREB1c followed by a single pulse Short-Term and Long-Term Facilitation of 5-HT doubled the normal amplitude of short-term In the course of studying the function of CREB1b, we facilitation evident at 10 min as compared to control, made the surprising finding that the expression of buffer-injected neurons ( Figure 8A ). In further contrast to CREB1␤ mRNA not only modulates long-term facilitacontrol cells, the injection of unphosphorylated CREB1c tion but also can modify short-term facilitation.
paired with one pulse of 5-HT also induced long-term We first found this modulation in the course of infacilitation at 24 hr ( Figure 8B ). Thus, in response to a jecting the antisense oligonucleotide (As III/V) that tarsingle pulse of 5-HT, the unphosphorylated CREB1c can gets the CREB1␤ mRNA. When this injection was folfacilitate both the short-and the long-term process. By lowed by one pulse of 5-HT, it almost doubled the contrast, the injection of the phosphorylated CREB1c amplitude of the short-term facilitation as compared to followed by a single pulse of 5-HT had no effect on the effect of a single pulse of 5-HT in control noninjected either short-term or long-term facilitation (Figures 8A neurons or in neurons injected with scrambled As SCIII/V and 8B). oligonucleotide ( Figure 7D ). How could this antisense Although CREB1a is colinear with CREB1c up to R87, oligonucleotide, directed against CREB1␤ mRNA, affect injection of the CREB1a protein into the cytoplasm of the short-term process? Blocking the translation of one sensory neurons had no effect on short-term facilitation. reading frame in bicistronic mRNAs often increases the This difference in activity between CREB1c and CREB1a translation of the other one (Kozak, 1986a) . We therefore may be due to the absence of the C-terminal DNA bindwondered whether, rather than simply reducing the ing and dimerization domain in CREB1c, to differences translation of the CREB1b protein, the As III/V oligonucleotide could also enhance the translation of CREB1c in the subcellular localization of the two proteins, or to effects of the twelve C-terminal amino acids present therefore coinjected the CREB1c protein and the CRE oligonucleotide and paired the injection with one pulse only in CREB1c.
of 5-HT. This coinjection led to a significant enhancement of short-term facilitation but did not induce longCREB1a and CREB1c Act Coordinately to Regulate the Transition from Short-to term facilitation ( Figures 8C and 8D) . Thus, the induction of long-term, but not the enhancement of short-term Long-Term Facilitation The injection of phosphorylated CREB1a without 5-HT facilitation by CREB1c paired with a single pulse of 5-HT requires CREB1a DNA binding activity. This experiment exposure induces long-term facilitation without inducing the short-term. Since the injection of CREB1c paired supports the idea that CREB1c modulates the action of CREB1a but is not sufficient to induce long-term synapwith a single pulse of 5-HT is sufficient to enhance shortterm facilitation and induce long-term facilitation, we tic changes. As a corollary, these findings indicate that CREB1c and CREB1a act coordinately to initiate the asked whether the long-term facilitation induced by CREB1c requires DNA binding activity of CREB1a. We long-term process. logical effect at all induce comparable CREB phosphorat 40 M; 2.8% Ϯ 3.2% at 8 M). Similarly, unphosylation (Bito et al., 1996; Deisseroth et al., 1996) . Our data phorylated recombinant wild-type CREB1c and mutated provide evidence that the phosphorylation of CREB1a is CREB1c S85A inhibit CaMKII activity in Aplysia neuronal both necessary and sufficient for the induction of longextracts (68.3% Ϯ 2.4% inhibition by CREB1c and term facilitation in Aplysia neurons and is likely a first 69.5% Ϯ 4.2% inhibition by CREB1c S85A, both 40 M).
step in the transcriptional switch from the short-term to The PKA-phosphorylated CREB1c inhibits CaMKII acthe long-term process. CREB1a phosphorylation intivity in Aplysia neuronal extracts significantly less creases in Aplysia neurons following in vivo exposure (22.1% Ϯ 6.8% inhibition at 40 M). Neither unphosphorto 5-HT, and interfering with CREB1a expression by ylated nor PKA-phosphorylated CREB1c affected PKA injecting antibodies or antisense oligonucleotides selecor PKC activity in vitro or in Aplysia neuronal extracts.
tively blocks long-term facilitation. Injection of recombiTo ask whether the CREB1c could interfere with calnant phosphorylated CREB1a into sensory neurons promodulin activation of CaMKII in Aplysia neurons, we duces about 50% of the induced long-term facilitation compared the physiological effect of injecting CREB1c by five pulses of 5-HT in the absence of 5-HT. Following to that of injecting the autoinhibitory peptide of CaMKII.
injection of CREB1a, a single pulse of 5-HT, which norAs with the injection of unphosphorylated CREB1c and mally induces short-term facilitation, induced long-term CREB1c S85A mutant, but not the PKA-phosphorylated facilitation comparable to that induced by five pulses of CREB1c, injection of the autoinhibitory peptide of CaMKII 5-HT. This experiment is the cellular counterpart of the into the Aplysia sensory neurons followed by one pulse behavioral experiments by Yin and Tully in Drosophila of 5-HT increased short-term facilitation and induced that showed that overexpression of the CREB2a activalong-term facilitation ( Figures 8A and 8B ) as compared tor can lead to long-term memory formation when paired to uninjected cells. Thus, the unphosphorylated CREB1c with a single training trial (Yin et al., 1995a) . parallels the calmodulin-binding CaMKII inhibitory peptide in blocking CaMKII activity in vitro and lowering CREB1a Expression Increases following threshold for both long-and short-term facilitation in Extended 5-HT Exposure sensory neurons. Phosphorylation of CREB1c by PKA Previous studies focused on the role of CREB1 proteins abolishes both of these effects.
in the initial switch to turn on long-term neuronal plasticity. Our data suggest that CREB1a is not only a key element in initiating the switch but may also have a role Discussion in the maintenance of long-term facilitation. We found that upon exposure to 5-HT in vivo CREB1a There is increasing evidence that the transcriptional activator CREB is important for long-term synaptic plasticis phosphorylated in at least two phases. The first phase, which occurs within 10-15 min after exposure to 5-HT, ity and long-term memory formation in Aplysia, Drosophila, and mice (Dash et al., 1990; Bourtchuladze et peaks at 20 min and returns to baseline within 40 min. This increase in CREB1a phosphorylation at S85 is not al., 1994; Yin et al., 1994 Yin et al., , 1995a . However, it has not previously been possible to demonstrate which specific accompanied by an increase in the concentration of the CREB1a protein and therefore most likely reflects the CREB/ATF1 or CREM isoforms participate in any of these instances of synaptic plasticity and memory storsequential activation of 5-HT receptor, adenylyl cyclase, and PKA. age. We have found that this problem may be simplified in Aplysia because there appears to be only one member However, if animals are exposed to 5-HT continuously for 1 hr-a procedure that gives rise to long-term sensitiof the CREB, CREM, and ATF1 family of genes: CREB1. We have characterized the specific isoforms of CREB1 zation in the animal-a second phase of CREB1a phosphorylation is induced, which now persists for at least that are expressed in Aplysia sensory neurons and manipulated the expression of these isoforms individually.
24 hr. This phosphorylation is detectable at 1 hr and is accompanied by an increase in the concentration of We find that the CREB1 gene encodes in the sensory neurons two alternatively spliced mRNAs, CREB1␣ and CREB1a protein. This suggests that CREB1a expression may be autoregulated, perhaps directly by CREB1a actikinetics than CREB1a. Since this phosphorylation turns off the facilitatory actions of CREB1c, the phosphorylavating the CRE regulatory sequences in the CREB1 gene. Earlier studies have indicated that mammalian tion of CREB1c may serve as a termination signal that serves to increase the threshold for subsequent signals CREB mRNA expression is induced following prolonged exposure to the antidepressant rolipram, a cAMP phosonce an action of 5-HT has been initiated. Thus, CREB1c appears to be a modulator of PKA-and CREB1a-mediphodiesterase inhibitor, or following exposure to drugs of abuse (Nibuya et al., 1996; Widnell et al., 1996) . ated transcription, not by acting on the transcriptional process itself, but rather by modifying the core cytoplasmic signal transduction pathways activating CREB1a.
CREB1b Is a Repressor Similar to Mammalian
Although the cytoplasmic location of a CREB1c isoform ICER and I-CREB is surprising, it is by no means unique to Aplysia. MamThe CREB1b polypeptide translated from the alternamalian CREB W and some forms of CREB␣ are similarly tively spliced CREB1␤ mRNA contains the bZIP domain cytoplasmic (Waeber et al., 1991; Hermanson et al., but lacks the N-terminal activation domain and the P 1996). The role of the cytoplasmic CREB1 isoforms in box of CREB1a. This CREB1b protein resembles the mammals and Drosophila remains to be elucidated, but mammalian ICER and I-CREB repressors structurally our data and the conservation of this splicing pattern and functionally (Molina et al., 1993; Walker et al., 1996) . among species suggest that they are likely to play a Consistent with its structure, Aplysia CREB1b forms horole in CREB1-mediated gene regulation as well as in modimers or heterodimers with CREB1a. These dimers synaptic plasticity. bind to CREs and inhibit CREB1a-mediated transactivation in F9 cells. Previously, we cloned the CREB2 gene (Bartsch et al., 1995) , which is structurally unrelated to
Experimental Procedures

CREB1. CREB2 also represses CREB1-mediated trans-
General Methods
activation in F9 cells and is a repressor of long-term
Standard manipulations of E. coli, S. cerevisiae, proteins, and nufacilitation. Thus, CREB1b and CREB2 may represent cleic acids were performed essentially as described (Harlow and parallel inhibitory pathways for regulating CREB1a- Lane, 1988; Ausubel et al., 1993; Bartsch et al., 1995) . mediated gene activation in Aplysia sensory neurons.
Plasmids, Cloning, and Transient Transfections and Reporter Assays
CREB1c Is a Cytoplasmic Regulator
Subcloning of CREB1 cDNAs was done by PCR using Pfu polymerOne of the most interesting components of the Aplysia ase (Stratagene). The initiation codons of the three ApCREB-1 iso-CREB1 regulatory unit, and the least well understood, forms were replaced by NcoI restriction sites. The CREB1 isoforms is the cytoplasmic regulator CREB1c. CREB1c is a cytowere cloned in the modified pET-30 for expression in E. coli and in plasmic protein with no direct transcriptional activity. It pRcRSV (Invitrogen). pRcRSV-PKA C-␣1 expressing the PKA catalacks the DNA-binding domain, the dimerization domain, lytic subunit was generously provided by R. Goodman. The luciferase reporter pGL3-5xCRE and transient transfection assays in F9 and the nuclear localization signal of CREB1a. cells were described previously (Bartsch et al., 1995) .
Injection of recombinant CREB1c significantly enhances both long-term and short-term facilitation. CREB1c
Immunocytochemistry does not induce long-term facilitation by itself, but reCREB1c and CREB1b ORF with N-terminal 6His tags were subquires the pairing with a 5-HT pulse. In addition, the DNA cloned from pET30 into pRcRSV and transfected into F9 cells with binding activity of CREB1a is necessary for CREB1c-pRSV-lacZ reporter plasmid. The F9 cells were immunostained with induced long-term facilitation. This long-term facilitation anti-6-His antibody (BABCO) 72 hr after transfection as described can be blocked by the CRE oligonucleotide, with which for Aplysia neurons (Martin et al., 1997) . The cells transfected with CREB1c does not interact directly, thus indicating that only the pRSV-lacZ plasmid did not show any staining.
CREB1c induces long-term facilitation through CREB1a.
Our data also suggest differential interaction of CREB1a
Aplysia CNS cDNA and Genomic Libraries and CREB1c with calmodulin and CaMKII. The splicing
Construction and Screening
that generates CREB1c modifies its P box as compared
The Aplysia CNS cDNA and genomic libraries were constructed in ZAP and FIX (Stratagene), respectively. Two partial CREB1 cDNA to CREB1a. It removes the S94, homologous to S142 clones were initially isolated by hybridization with rat CREB cDNA in mammalian CREB1. Phosphorylation in mammals at (generously provided by R. Goodman) at Tm-33ЊC. The full-length S142 by CaMKII is inhibitory to CREB transactivation CREB1 cDNAs and genomic clones were isolated by subsequent mediated by PKA or CaMKIV (Sun et al., 1994) . CREB1c
high stringency hybridization screening of corresponding libraries.
is phosphorylated by PKA and PKC, but although the A total of 13 cDNA clones (10 corresponding to CREB1␤ mRNA and consensus phosphorylation site for CaMKII at S85 in 3 to CREB1␣ mRNA) and 16 genomic clones were sequenced.
CREB1c remains intact, it is not readily phosphorylated by CaMKII in vitro. In fact, CREB1c inhibits CaMKII activ- 5-HT, CREB1c is phosphorylated in vivo but with slower
